The impact of donor insemination on the risk of preeclampsia: a systematic review and meta-analysis.

[1]  E. Triche,et al.  Cumulative exposure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia. , 2014, Journal of reproductive immunology.

[2]  A. Tranquilli.  Introduction to ISSHP new classification of preeclampsia. , 2013, Pregnancy hypertension.

[3]  S. Robertson,et al.  Seminal Fluid and the Generation of Regulatory T Cells for Embryo Implantation , 2013, American Journal of Reproductive Immunology.

[4]  J. V. D. van der Post,et al.  Molecular genetics of preeclampsia and HELLP syndrome - a review. , 2012, Biochimica et biophysica acta.

[5]  S. Shiboski,et al.  Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. , 2012, The American journal of pathology.

[6]  R. Gilchrist,et al.  TGF-β Mediates Proinflammatory Seminal Fluid Signaling in Human Cervical Epithelial Cells , 2012, The Journal of Immunology.

[7]  Jaime Saavedra-Saavedra,et al.  Preeclampsia in infertile patients subjected to homologous and heterologous insemination in the centro de Biomedicina Reproductiva del Valle - Fecundar, Cali, Colombia , 2012 .

[8]  O. Chazara,et al.  Maternal KIR and fetal HLA‐C: a fine balance , 2011, Journal of leukocyte biology.

[9]  R. Asmar,et al.  Pre-eclampsia: pathophysiology, diagnosis, and management , 2011, Vascular health and risk management.

[10]  T. Hulsey,et al.  Epidemiological studies on primipaternity and immunology in preeclampsia--a statement after twelve years of workshops. , 2011, Journal of reproductive immunology.

[11]  G. Dekker,et al.  The etiology of preeclampsia: the role of the father. , 2011, Journal of reproductive immunology.

[12]  H. Ploegh,et al.  The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation , 2010, The Journal of experimental medicine.

[13]  A. Shennan,et al.  The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[14]  K. Manley,et al.  The Glycoprotein B Disintegrin-Like Domain Binds Beta 1 Integrin To Mediate Cytomegalovirus Entry , 2010, Journal of Virology.

[15]  E. Kolibianakis,et al.  Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? , 2010, Fertility and sterility.

[16]  G. Dekker,et al.  Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. , 2009, Journal of reproductive immunology.

[17]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[18]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[19]  S. Hernández-Díaz,et al.  Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study , 2009, BMJ : British Medical Journal.

[20]  J. Trowsdale,et al.  NK receptor interactions with MHC class I molecules in pregnancy. , 2008, Seminars in immunology.

[21]  M. Martel.  Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. , 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[22]  S. Robertson,et al.  Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells. , 2007, Molecular human reproduction.

[23]  N. Kiviat,et al.  Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. , 2007, Fertility and sterility.

[24]  S. Robson,et al.  Expression of Angiogenic Growth Factors by Uterine Natural Killer Cells during Early Pregnancy Poietin (ang)1, Placental Growth Factor, Transform- Ing Growth Factor-␤1 (tgf-␤1), and Vascular En- Dothelial Growth Factor (vegf)-c Were Measured by Enzyme-linked Immunosorbent Assay. Angioge- Nin, Ang2, , 2006 .

[25]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[26]  U. Markert.  Immunology of pregnancy , 2005 .

[27]  B. Sibai.  Diagnosis, prevention, and management of eclampsia. , 2005, Obstetrics and gynecology.

[28]  M. Carrington,et al.  Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success , 2004, The Journal of experimental medicine.

[29]  R. Ness,et al.  Barrier Methods, Length of Preconception Intercourse, and Preeclampsia , 2004, Hypertension in pregnancy.

[30]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[31]  C. Mengelle,et al.  Risk of cytomegalovirus transmission by cryopreserved semen: a study of 635 semen samples from 231 donors. , 2003, Human reproduction.

[32]  H. Sangi-Haghpeykar,et al.  Sperm exposure and development of preeclampsia. , 2003, American journal of obstetrics and gynecology.

[33]  E. Masson,et al.  Long-term sexual co-habitation offers no protection from hypertensive disease of pregnancy. , 2001, Human reproduction.

[34]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[35]  V. Allgar,et al.  The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. , 1999, Human reproduction.

[36]  A. Venn,et al.  Perinatal and obstetric outcomes of donor insemination using cryopreserved semen in Victoria, Australia. , 1999, Human reproduction.

[37]  G. Smith,et al.  Increased incidence of preeclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. , 1997, American journal of obstetrics and gynecology.

[38]  J. Fleiss.  Review papers : The statistical basis of meta-analysis , 1993 .

[39]  I. Macgillivray,et al.  The classification and definition of the hypertensive disorders of pregnancy. , 1988, American journal of obstetrics and gynecology.

[40]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[41]  S. Karumanchi,et al.  Preeclampsia and the Anti-Angiogenic State. , 2011, Pregnancy hypertension.

[42]  J. Walker.  Inflammation and preeclampsia. , 2011, Pregnancy hypertension.

[43]  M. Knöfler.  Critical growth factors and signalling pathways controlling human trophoblast invasion. , 2010, The International journal of developmental biology.

[44]  J. Bulmer,et al.  Immune cells in the placental bed. , 2010, The International journal of developmental biology.

[45]  C. Berek,et al.  Chemical immunology and allergy , 2003 .

[46]  O. Hovatta,et al.  LACK OF PREVIOUS EXPOSURE TO PATERNAL ANTIGENS DOES NOT PREDISPOSE TO HYPERTENSIVE PREGNANCY COMPLICATIONS , 1998 .